Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Express Scripts
Fish and Richardson
QuintilesIMS
McKesson
Citi
Cipla
Accenture

Generated: June 21, 2018

DrugPatentWatch Database Preview

DELATESTRYL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Delatestryl patents expire, and when can generic versions of Delatestryl launch?

Delatestryl is a drug marketed by Endo Pharms and is included in one NDA.

The generic ingredient in DELATESTRYL is testosterone enanthate. There are sixty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.
Summary for DELATESTRYL
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
Formulation / Manufacturing:see details
DailyMed Link:DELATESTRYL at DailyMed
Drug patent expirations by year for DELATESTRYL

US Patents and Regulatory Information for DELATESTRYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms DELATESTRYL testosterone enanthate INJECTABLE;INJECTION 009165-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Endo Pharms DELATESTRYL testosterone enanthate INJECTABLE;INJECTION 009165-003 Approved Prior to Jan 1, 1982 AO RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cerilliant
US Army
Argus Health
Dow
Queensland Health
Deloitte
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.